Explore how MGI’s genomic innovation is transforming rare diseases (and even dual diagnoses) care in Turkey and around the globe from Dr. Serdar Ceylaner and Alice Peng.
All in Interview
#354 How Pharmacogenomics is Revolutionizing Drug Prescriptions
Quest Diagnostics' Kristy Bouvier and Kathleen O’Brien explore how pharmacogenetics testing can optimize medications, prevent side effects, and improve treatment.
#353 Advancing Telomere Research: A Breakthrough Leads to Clinical Trial
Live from NYC’s Cocktails & Chromosomes, patient advocate Jena Robertson and researcher Dr. Will Mannherz share personal stories and new breakthroughs bringing telomere biology disorders to a clinical trial this fall.
#352 Why Biotech Will Define the 21st Century
Gene Pool Media’s RealPharma episode features British investor and author Andrew Craig who shares how biotechnology is our future and is being driven by innovations in CRISPR, AI, and genomic science.
#350 How To Talk About DNA Without Losing People: Strategies Part 2
Former NIH communicators Jenny Montooth, Sarah Alex Bates, and Britny Kish (Founders of The Science Underground) weigh in on science communication strategies including their memes that took them from 15M to 80M impressions.
#349 Ethical Dilemmas in Genetic Testing: Dr. Madison Kilbride Weighs In
Bioethicist Dr. Madison Kilbride sheds light on controversial ethical issues surrounding genetic testing through this interview led by Sarah Lawrence student Shaun Miller.
#345 How To Talk About DNA Without Losing People: Strategies Part 1
Former NIH communicators Jenny Montooth, Sarah Alex Bates, and Britny Kish (Founders of The Science Underground) weigh in on science communication strategies including their memes that took them from 15M to 80M impressions.
#344 Trans and Gender Diverse Patients' Experiences with Reproductive Healthcare
“DNA Dialogues” episode discussing how reproductive healthcare providers can provide a more gender affirming experience and what trans and gender diverse (TGD) patients want.
#343 The First Child to Receive CRISPR for Duchenne? A Father’s Fight for a Cure
When William was diagnosed with DMD, his family set out to raise $2.2 million to design a cure with CRISPR.
#342 $10 Million for a Cure: Donating Mr. Beast’s “Beast Games” Winnings For Son’s Creatine Transporter Deficiency
Behind the scenes of Beast Games, and the bigger battle the Allens are fighting.
#340 How Podcasting Shaped A Genetics Career: Dr. Matt Burgess Interviews Kira Dineen
Episode drop from Demystifying Genetics, a show in our brand new science podcast network, Gene Pool Media!
#339 Inherited Leukemia: Exploring Genetic Risk and Early Detection
Episode drop from All Access DNA, a show in our brand new science podcast network, Gene Pool Media!
#338 Social Determinants of Health and Mental Health in Urea Cycle Disorders
Neuropsychologist Kendra Bjoraker and metabolic nurse practitioner Erika Vucko share how clinicians can better support patients with UCDs by addressing SDOH and mental health challenges.
#337 How to Get Your Research Published: Insight from Wiley’s Advanced Portfolio Journal Editors
Submitting a research paper? Hear from journal editors Drs. Lei Lei and Alanna Gannon as they share what you need to know to successfully get published.
#336 Sharpening Genetic Counseling Skills with GC+ Academy
The brand new on-demand GC+ Academy has launched and Carli Andrews shares how these CEUs will elevate your career.
#333 Approaching a Down Syndrome Diagnosis with Care
To celebrate World Down Syndrome Day the Founder of Jack’s Basket, Carissa Carroll, shares how healthcare providers can approach a Down syndrome diagnosis with care and neutrality.
#332 Building Stronger Rare Disease Organizations: NORD CEO’s Insight
An in-person conversation at the 2025 Connecticut Rare Disease Forum with The National Organization for Rare Disorder’s President/CEO Pam Gavin sharing how patient advocacy organizations are vital to research and development.
#329 Preventive Genomic Medicine: Saving Lives and Healthcare Costs with MyOme
Shifting healthcare from reactive to proactive, Dr. Matthew Rabinowitz breaks down how preventive genomic medicine can save $200 billion annually in healthcare costs.
#328 Breakthrough Biotech: CAR-Ts for Solid Tumors & Engineered Bacteria for Rare Diseases
Interviews recorded at BIO’s CEO and Investor Conference with two biotech executives: Cellinfinty Bio’s Dr. Premal Patel and Azitra’s Dr. Travis Whitfill.
#326 How DNA Solves Crimes: The Forensic Science Behind True Crime
Dr. Henry Erlich on DNA Evidence, Exonerations, and Ethical Dilemmas.